Title Phenotypesort descending Institution Algorithm Type Total Cases Total Controls PPV Sensitivity
Lipids Northwestern Implementation Lipids Northwestern University Case Only 0.92
Lipids Implementation - Columbia Lipids Columbia University Case Only
PAD Marshfield Implementation Peripheral Arterial Disease - 2012 Marshfield Clinic Research Foundation Case Only 0.88 0.97
PAD Mayo Implementation Peripheral Arterial Disease - 2012 Mayo Clinic Case Only 0.91 0.86
PAD Northwestern Implementation Peripheral Arterial Disease - 2012 Northwestern University Case, Control 0.95, 1.00 1.00, 0.82
RBC Marshfield Implementation Red Blood Cell Indices Marshfield Clinic Research Foundation Case Only 0.96 0.87
RBC Mayo Implementation Red Blood Cell Indices Mayo Clinic Case Only 0.98 0.94
RBC Northwestern Implementation Red Blood Cell Indices Northwestern University Case Only 0.98 0.91
RBC Implementation - Columbia Red Blood Cell Indices Columbia University Case Only
T2D Marshfield Implementation Type 2 Diabetes Mellitus Marshfield Clinic Research Foundation Case, Control 0.99, 0.98 1.00, 0.98
T2D Northwestern Implementation Type 2 Diabetes Mellitus Northwestern University Case, Control 0.98, 1.00 1.00, 1.00
T2D Vanderbilt Implementation Type 2 Diabetes Mellitus Vanderbilt University Case, Control 1.00, 1.00
T2DM Implementation - Columbia Type 2 Diabetes Mellitus Columbia University Case, Control 293 478
WBC Marshfield Implementation White Blood Cell Indices Marshfield Clinic Research Foundation Case Only 0.90 0.88
WBC Northwestern Implementation White Blood Cell Indices Northwestern University Case Only 0.85 1.00
WBC Implementation - Columbia White Blood Cell Indices Columbia University Case Only
Resistant hypertension Implementation - Columbia Resistant hypertension Columbia University Case, Control 249 1,031
CDiff NU implementation - May 2012 chart review Clostridium Difficile Colitis Northwestern University Case, Control 0.90, 0.95 0.95
Group Health implementation Clostridium Difficile Colitis Group Health Cooperative Case, Control 0.92, 0.88
Vanderbilt implementation Clostridium Difficile Colitis Case, Control 1.00, 1.00
Marshfield C-diff implementation Clostridium Difficile Colitis Marshfield Clinic Research Foundation Case, Control 21 10 1.00, 1.00
CDiff Implementation - Columbia Clostridium Difficile Colitis Columbia University Case, Control 107 139
Geisinger c.Diff eMERGE3 Implementation Clostridium Difficile Colitis Geisinger Case, Control 20 20 1.00, 1.00 1.00, 1.00
VU E3 implementation Clostridium Difficile Colitis Vanderbilt University Medical Center Case, Control
Mayo Clinic eMERGE III Implementation Clostridium Difficile Colitis Mayo Clinic Case, Control 103 4,494

Pages